Definitive Contract 00264200009D264002249
Award Date 9/28/00
Potential Completion Date 9/29/06
Potential Value $6.2M
Funding Federal Agency
Not listed Contracting Federal Agency
Ultimate Awardee
NAICS Category
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Texas, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for veterinary and animal care services. The $17,369,042.37 Definitive Contract has a period of performance ending on September 11, 2013 and was awarded on August 29, 2003 by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH). The contract does not have a set-aside designation. As a...
- This is a research and development contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to the University of Texas MD Anderson Cancer Center (MD Anderson), a state-controlled higher education institution and comprehensive cancer treatment and research center. The $32,129,968.00 indefinite-delivery, indefinite-quantity (IDIQ) contract, awarded on September 26, 2000, supports the acquisition, testing, transportation, and housing of non-human...
- This federal contract was awarded by the Department of Health and Human Services' Food and Drug Administration to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract, valued at $283,546.12, is for a study titled "Modular Application of Surface Technology for the Generation of Antigen-Specific T Cells." It is a definitive contract with a cost-no-fee pricing type, awarded on September 13, 2019 with a completion date of...
- This is a three-year, $13,481,325.00 definitive contract awarded by the National Cancer Institute (NCI) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract supports a Phase II chemoprevention clinical trial in patients with adenomatous polyposis coli, a genetic condition that increases cancer risk. The contract does not have a small business set-aside designation. MD Anderson Cancer Center, a comprehensive cancer research and...
- This is an indefinite delivery contract (IDC) awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson) for $1,967,472.00 to provide support services for medical radiation dosimetry for epidemiology studies. The contract does not have a set-aside designation. MD Anderson, a comprehensive cancer treatment and research center that is part of the University of Texas System, has extensive...
- This is a federal contract award made by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The award, valued at $2,387,945.37, is for biomedical research and development activities, with an ultimate completion date of August 21, 2013. The contract is a definitive contract with a cost-no-fee pricing type, and does not have...
- This is a modification to a federal contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson). The original contract was a definitive cost-no-fee contract awarded on February 15, 2003 with a ceiling value of $8,606,292. This modification is to deobligate FY06 funds. MD Anderson, a U.S. state government entity and academic medical center, has been the prime contractor as...
- This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson). The contract, valued at $20,094,324.00, is for the provision of cancer information services. The contract is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of January 14, 2010. MD Anderson, a comprehensive cancer treatment and research center, has received...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) to The University of Texas MD Anderson Cancer Center (MD Anderson) for $972,225.00 to provide medical physics peer review of radiation therapy quality assurance operations. The contract has a firm fixed price structure and a period of performance through March 12, 2025. MD Anderson is a child entity of the University of Texas System, which has a history of receiving federal contracts and grants across various...
- This is a federal contract award from the Office of Logistics and Acquisition Operations, a component of the National Institutes of Health (NIH), to The University of Texas M.D. Anderson Cancer Center (MD Anderson). The contract, with a ceiling value of $171,500.00, is for the acquisition, testing, transportation, and housing of non-human primate research colonies to support infectious disease and immunology studies at NIH facilities. The contract is a delivery order under a larger indefinite...